ERBB2 and breast cancer: More particularly, HER2+ BC represents 15-20% of all breast tumors and is defined by the Erb-B2 receptor tyrosine kinase 2 (ERBB2)/HER2 gene amplification that leads to overexpression of the transmembrane tyrosine kinase receptor protein [1,2].